A Phase 1 Open-Label, Non-Randomized, Single-Dose, Pharmacokinetic Study Evaluating Staccato Alprazolam 1 mg Inhaler in Smoker Versus Non-Smoker Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2019
Price : $35 *
At a glance
- Drugs Alprazolam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Engage Therapeutics
- 04 Dec 2019 According to an Engage Therapeutics media release, data from this study will be presented at the American Epilepsy Society Annual Meeting (AES 2019), which is being held Dec. 6-10, at the Baltimore Convention Center.
- 14 Dec 2018 Status changed from recruiting to completed.
- 01 Aug 2018 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.